494 related articles for article (PubMed ID: 8551486)
21. White coat hypertension and white coat effect. Similarities and differences.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
[TBL] [Abstract][Full Text] [Related]
22. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
[TBL] [Abstract][Full Text] [Related]
23. A study of the white-coat phenomenon in patients with primary hypertension.
Zhu N; Bu M; Chen D; Li T; Qian J; Yu Q; Chen Q; Wan C; Qu H; Zhu M; Zou X
Hypertens Res; 2008 Jan; 31(1):37-41. PubMed ID: 18360016
[TBL] [Abstract][Full Text] [Related]
24. Office blood pressure and 24-hour ambulatory blood pressure measurements: high proportion of disagreement in resistant hypertension.
Rodrigues CS; Bloch KV; da Rocha Nogueira A
J Clin Epidemiol; 2009 Jul; 62(7):745-51. PubMed ID: 19128937
[TBL] [Abstract][Full Text] [Related]
25. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
26. Home blood pressure measurement may lead to less strict control of office blood pressure.
Eto K; Tsuchihashi T; Ohta Y; Onaka U; Ueno M
Clin Exp Hypertens; 2008 Apr; 30(3):225-31. PubMed ID: 18425702
[TBL] [Abstract][Full Text] [Related]
27. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
[TBL] [Abstract][Full Text] [Related]
28. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
29. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
Bookstaver DA; Hatzigeorgiou C
Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
Podjarny E; Korzets Z; Bernheim J
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
[TBL] [Abstract][Full Text] [Related]
32. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
Lorgelly P; Siatis I; Brooks A; Slinn B; Millar-Craig MW; Donnelly R; Manning G
Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
[TBL] [Abstract][Full Text] [Related]
33. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
[TBL] [Abstract][Full Text] [Related]
34. Comparisons of ambulatory blood pressure monitoring and repeated office measurements in primary care.
Pearce KA; Evans GW; Summerson J; Rao JS
J Fam Pract; 1997 Nov; 45(5):426-33. PubMed ID: 9374969
[TBL] [Abstract][Full Text] [Related]
35. Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls.
Svensson P; de Faire U; Niklasson U; Ostergren J
J Hum Hypertens; 2004 Mar; 18(3):193-200. PubMed ID: 14973514
[TBL] [Abstract][Full Text] [Related]
36. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
Widimský J; Balazovjech I; Lánská V
Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
[TBL] [Abstract][Full Text] [Related]
37. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association.
Pickering TG; Miller NH; Ogedegbe G; Krakoff LR; Artinian NT; Goff D; ; ;
J Cardiovasc Nurs; 2008; 23(4):299-323. PubMed ID: 18596492
[TBL] [Abstract][Full Text] [Related]
38. Use of automated office blood pressure measurement to reduce the white coat response.
Myers MG; Valdivieso M; Kiss A
J Hypertens; 2009 Feb; 27(2):280-6. PubMed ID: 19155785
[TBL] [Abstract][Full Text] [Related]
39. [Is the white coat effect an alert reaction?].
Mpio I; Ducher M; Cerutti C; Fauvel JP
Arch Mal Coeur Vaiss; 2004; 97(7-8):757-61. PubMed ID: 15506061
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing white-coat effect.
Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
